Navigation Links
Study: Modafinil is effective in treating excessive sleepiness
Date:10/15/2007

arameters were observed in less than one percent of patients in modafinil-treated patients at the final visit.

Modafinil is well tolerated. Furthermore, it appears from these prospective research studies that daily modafinil administration confers a low risk of adverse events or severe adverse events. These results make for a positive risk-benefit ratio for using modafinil to treat excessive sleepiness in patients with shift work sleep disorder, OSA and narcolepsy, said Dr. Roth.

The American Academy of Sleep Medicine (AASM) recommends that people who suspect that they might have a sleep disorder see a primary care physician or a sleep medicine specialist for proper diagnosis and to discuss treatment options before treatment with medications is undertaken.

While modern hypnotics are considered safe, individuals should be aware that, like all medications, side effects may occur in patients.

Sleep medications are effective and safe treatments when used properly and judiciously by a patient who is under the supervision of a sleep medicine or primary care physician.


'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Counter study: cholesterol drugs no good in preventing colon cancer
2. A strategic study: Soy diet makes heart disease to worsen in male mice
3. Bird Flu Pandemic Study: Clerical & Support Staff May Stay At Home
4. Study: Older Pancreatic Cancer Surgery Survivors Live Long
5. New Study: Pine Bark Significantly Reduces Endometriosis
6. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
7. Inhaled Steroids Safe & Effective for Children with Asthma
8. Morning after pill effective up to five days after having unprotected sex
9. Distraction therapy found very effective in postoperative patients
10. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
11. TELITHROMYCIN - the proven effective new drug for cap
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Heat Therapy May Help Prevent Esophageal Cancer 2Health News:New therapy enlists immune system to boost cure rate in a childhood cancer 2Health News:More Living Longer With Advanced Colon Cancer 2Health News:More Living Longer With Advanced Colon Cancer 3Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 2Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 3Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 4Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 2Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 3Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 4Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 5Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 6Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 7Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 8
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 1Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 3Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 1Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 2Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 3Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 1Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 2